Hashimoto’s Thyroiditis or Hashimoto’s Disease
Hashimoto’s disease is an autoimmune pathological condition that affects the thyroid gland. During this condition the human body produces antibodies (auto-antibodies) that act against the thyroid gland.
Inflammation caused by this phenomenon is also known as chronic lymphocytic thyroiditis and can often result in an underactive thyroid gland (hypothyroidism).
Diagnosis of Real Causes & Treatment of Hashimoto’s Thyroiditis
- Gradual restoration of cellular function
- Personalized therapeutic protocols, without chemical residues and excipients
- Treating the real causes
- Therapeutic formulas that work alone or in combination with any other medication
- Adopting a Molecular / Therapeutic Nutrition Plan
Symptoms of Hashimoto’s disease may not be evident in the beginning as the disease can progress slowly over a course of many years.
The symptoms that usually lead a physician to test for Hashimoto’s disease are similar to those of Hypothyroidism and include dizziness, skin dryness, constipation, fatigue, cold intolerance, fluid retention, decreased libido, fragile hair, irregular period, weight gain/ difficulty losing weight, palpitations or hoarse voice.
Previous thyroid gland problems or a goiter can also indicate the existence of Hashimoto’s disease.
Pathophysiology of Hashimoto’s Disease
The thyroid is a butterfly-shaped gland located at the base of the larynx. This gland can be parallelized as the power house of the metabolism. The thyroid uses iodine and tyrosine in order to produce two basic hormones, thyroxine (T4) and triiodothyronine (T3).
During Hashimoto’s disease, the levels of T3 and T4 are very low and subsequently the levels of TSH (thyroid stimulating hormone) are too high. Being classified as an autoimmune disease, means that the immune system mistakenly attacks the thyroid gland. More specifically, the influx of CD4 and T helper cells along with the action of auto-antibodies produced by B cells against thyroglobulin (TG) and thyroid peroxidase (TPO), cause the gradual destruction of the thyroid gland.
Epidemiology and risk factors
Hashimoto’s disease is one of the most common endocrine disorders. It is estimated that in the USA, approximately 4.78% of the population have an undiagnosed thyroid dysfunction. In Europe an estimated 1-2% of the population suffers from this disease.
Hashimoto’s is more common among women aged 30 to 50 years old and can coexist along with other autoimmune diseases such as Rheumatoid arthritis, lupus and type 1 Diabetes. Other risk factors include a positive family history for Hashimoto’s and exposure to irradiation.